Autoantibody IgG subclasses to recombinant antigens and the role of bacterial stimuli in primary biliary cirrhosis

Hepatology Research

Volumn 39, Issue 9, 2009, Pages 874-881

  Kawai, Toshihiro ^a   Hosoya, Naomi ^a   Moritoki, Yuki ^b   Kajiyama, Yusuke ^a   Watanabe, Masashi ^a   Takai, Atsuko ^a   Selmi, Carlo ^b,c   Gershwin, Eric M ^b   Miyakawa, Hiroshi ^a   Kikuchi, Kentaro ^a  

^a TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Antimitochondrial antibody; Autoimmune cholangitis; Molecular mimicry

Indexed keywords

CD38 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; MITOCHONDRION ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD20+ B LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; ETHNIC DIFFERENCE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; JAPANESE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MITOGENICITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; STIMULUS RESPONSE; UNITED STATES;

EID: 69949091318     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00533.x     Document Type: Article

References (32)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
2. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007; 28: 76-84.
3. Foreman AL, Van de Water J, Gougeon ML, Gershwin ME. B cells in autoimmune diseases: Insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 2007; 6: 387-401.
4. Shimoda S, Miyakawa H, Nakamura M et al. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008; 31: 110-15.
5. Blank M, Shoenfeld Y. B cell targeted therapy in autoimmunity. J Autoimmun 2007; 28: 62-8.
6. Miyakawa H, Tanaka A, Kikuchi K et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.
7. French MA, Bernstein RM. Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes. Ann Rheum Dis 1987; 46: 436-40.
8. Surh CD, Cooper AE, Coppel RL et al. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology 1988; 8: 290-5.
9. Zhang L, Weetman AP, Jayne DR et al. Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis. Clin Exp Immunol 1992; 88: 56-61.
10. Maran R, Dueymes M, Adler Y, Shoenfeld Y, Youinou P. Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members. J Clin Immunol 1994; 14: 323-6.
11. Rigopoulou EI, Davies ET, Bogdanos DP et al. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int 2007; 27: 1226-31.
12. Pan Q, Hammarstrom L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000; 178: 99-110.
13. Riesen WF, Skvaril F, Braun DG. Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand J Immunol 1976; 5: 383-90.
14. Hammarstrom L, Smith CI. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19: 122-33.
15. Selmi C, Gershwin ME. Bacteria and human autoimmunity: The case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406-10.
16. Lang KS, Burow A, Kurrer M, Lang PA, Recher M. The role of the innate immune response in autoimmune disease. J Autoimmun 2007; 29: 206-12.
17. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 2008; 7: 204-8.
18. Frazer IH. Autoimmunity and persistent viral infection: Two sides of the same coin? J Autoimmun 2008; 31: 216-18.
19. Kikuchi K, Lian ZX, Yang GX et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005; 128: 304-12.
20. Kadokawa Y, Omagari K, Hazama H et al. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003; 36: 203-10.
21. Moteki S, Leung PS, Coppel RL et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24: 97-103.
22. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 1-7.
23. Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME. Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun 2005; 6: 543-56.
24. Invernizzi P, Selmi C, Poli F et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 controls. Hepatology 2008; 48: 1906-12.
25. Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 2008; 12: 173-85, ix.
26. Iwayama T, Leung PS, Rowley M et al. Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens. Int Arch Allergy Immunol 1992; 99: 28-33.
27. Lin L, Gerth AJ, Peng SL. CpG DNA redirects class-switching towards "Th1-like"Ig isotype production via TLR9 and MyD88. Eur J Immunol 2004; 34: 1483-7.
28. Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006; 203: 553-61.
29. Moritoki Y, Lian ZX, Wulff H et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 2007; 45: 314-22.
30. Mayumi M, Kuritani T, Kubagawa H, Cooper MD. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help. J Immunol 1983; 130: 671-7.
31. Dimitrov JD, Vassilev TL, Andre S, Kaveri SV, Lacroix-Desmazes S. Functional variability of antibodies upon oxidative processes. Autoimmun Rev 2008; 7: 574-8.
32. Miyakawa H, Tanaka A, Selmi C et al. Serum reactivity against bacterial pyruvate dehydrogenase: Increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clin Dev Immunol 2006; 13: 289-94.